J Med Drug Rev 2011;1;45-52 (Review-Artikel in deutscher Sprache) Belatacept is a new treatment option for the prevention of acute organ rejection in patients after kidney transplantation. Its mode of action totally differs from all known therapies. Belatacept is a selective blocker of T-cell activation, which plays a big role […]